| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |